Skip to main content Skip to footer
Press releases
Purdue Pharma L.P. Selects Cognizant to Optimize its Core IT Platform to Improve Business Efficiency and Drive Enterprise Agility

TEANECK, N.J., May 12, 2015 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that Purdue Pharma L.P., a leading pharmaceutical company, has selected Cognizant to optimize its core IT platform to improve business efficiency and drive enterprise agility.

Cognizant Logo

Engaged in the research, development, production, and marketing of prescription and over-the-counter medicines and healthcare products, Purdue Pharma is an industry leader in pain medication research. To manage its complete range of business applications on the SAP platform, including manufacturing, supply chain, and quality systems, Purdue Pharma is working with Cognizant to simplify and standardize its core application processes and create an environment for enhanced collaboration among its entire ecosystem. This enables the company to focus on improving patients' lives and serving the healthcare community.

At a new associated Purdue manufacturing facility in Durham County, North Carolina, Cognizant will help extend Purdue's core SAP and integrated application suite within the timelines defined by the project team for manufacturing commercial batches in the new plant.

"We have had a long-standing, successful relationship with Cognizant," said Larry A. Pickett, Jr., Vice President and Chief Information Officer, Purdue Pharma. "As we embarked on optimizing our business processes to improve efficiency and drive innovation, particularly on the SAP platform and related business applications, we selected Cognizant for its strong capabilities in SAP and deep knowledge of our business, as well as its ability to quickly align with our organizational goals and needs. Cognizant's approach has ensured continuity of business critical processes while simplifying our operations and driving higher levels of efficiency. We are now renewing our focus and combined energies on growing our business and innovating for the future."

"In the rapidly evolving and regulated pharmaceutical market, leading companies like Purdue Pharma are optimizing how they build, manage and operate their core IT platforms to improve efficiency and agility," said Shankar Narayanan, Global Head Life Sciences at Cognizant. "Cognizant's deep pharmaceutical business expertise as well as our supply chain and manufacturing solutions enabled us to help Purdue Pharma meet these efficiency and innovation requirements while standardizing the core application processes and procedures that support their value chain."

About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice is committed to helping change millions of lives for the better by working with clients to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness. With over $3 billion in annualized revenue, Cognizant's healthcare practice is consistently ranked among the top 10 on the Healthcare Informatics Top 100. Cognizant serves 28 of the top 30 global pharmaceutical companies, 16 of the top 20 health plans in the U.S., 4 of the top 5 pharmacy benefit management companies in the U.S., 9 of the top 10 biotech companies, and 12 of the top 15 medical device companies. With a large team of dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, the practice provides domain-aligned consulting, IT, business process and analytics solutions globally.

About Cognizant
Cognizant (NASDAQ: CTSH) is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's leading companies build stronger businesses. Headquartered in Teaneck, New Jersey (U.S.), Cognizant combines a passion for client satisfaction, technology innovation, deep industry and business process expertise, and a global, collaborative workforce that embodies the future of work. With over 100 development and delivery centers worldwide and approximately 217,700 employees as of March 31, 2015, Cognizant is a member of the NASDAQ-100, the S&P 500, the Forbes Global 2000, and the Fortune 500 and is ranked among the top performing and fastest growing companies in the world. Visit us online at www.cognizant.com or follow us on Twitter: Cognizant

About Purdue Pharma L.P.
Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on chronic pain. Headquartered in Stamford, Connecticut, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.

Logo - http://photos.prnewswire.com/prnh/20110329/NY67603LOGO

SOURCE Cognizant

For further information: U.S. - Jodi Sorensen, +1-201-294-5358, jodi.sorensen@cognizant.com | Europe - Grazia Valentino-Boschi, + 33 (0)6 07 85 80 63, grazia.valentino-boschi@cognizant.com | Asia-Pac - Harsh Kabra, +91-855-188-2111, harsh.kabra@cognizant.com
Customers

Connect with Cognizant

Careers

Be part of our journey to make a difference.

Contact

Let’s start a conversation.

Investors

View prior earnings releases and more.